Szeman Ruby Chan
Impact in
- Oncology top 5%
- Viral-associated cancers and disorders
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 10
- Cytokine Signaling Pathways and Interactions 5
- Viral-associated cancers and disorders 3
-
- Immune Cell Function and Interaction 4
- Immunotherapy and Immune Responses 2
- Co-authors
- Bala Chandran (3 shared papers)Clark Bloomer (2 shared papers)Robert D. Schreiber (6 shared papers)Amy M. Fowler (4 shared papers)Alexis K. Smith (1 shared paper)Natasha Girgis (1 shared paper)Raluca Verona (1 shared paper)Iqbal S. Grewal (1 shared paper)
- Journals
- Journal of Nuclear Medicine (2 papers)Virology (2 papers)Cell Death and Differentiation (1 paper)Clinical Cancer Research (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Szeman Ruby Chan
17 papers receiving 768 citations
Peers
Comparison fields: 5 of 61
- Oncology 471
- Immunology 259
- Epidemiology 198
- Cancer Research 85
- Infectious Diseases 66
Countries citing papers authored by Szeman Ruby Chan
This map shows the geographic impact of Szeman Ruby Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szeman Ruby Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szeman Ruby Chan more than expected).
Fields of papers citing papers by Szeman Ruby Chan
This network shows the impact of papers produced by Szeman Ruby Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szeman Ruby Chan. The network helps show where Szeman Ruby Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Szeman Ruby Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 143 | |
| 2 | 2017 | 141 | |
| 3 | 1998 | 94 | |
| 4 | 1998 | 77 | |
| 5 | 2012 | 59 | |
| 6 | 2000 | 51 | |
| 7 | 2013 | 48 | |
| 8 | 2019 | 38 | |
| 9 | 2013 | 37 | |
| 10 | 2014 | 33 | |
| 11 | 2022 | 18 | |
| 12 | 2020 | 9 | |
| 13 | 2016 | 8 | |
| 14 | 2017 | 7 | |
| 15 | 2015 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2022 | 2 |
About Szeman Ruby Chan
Szeman Ruby Chan is a scholar working on Oncology, Immunology, Genetics, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 777 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), Immune Cell Function and Interaction (4 papers), Estrogen and related hormone effects (3 papers), Viral-associated cancers and disorders (3 papers), Herpesvirus Infections and Treatments (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Immunotherapy and Immune Responses (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). The work is most often cited by research in Oncology (471 citations), Immunology (259 citations), Epidemiology (198 citations), Cancer Research (85 citations) and Infectious Diseases (66 citations). Szeman Ruby Chan has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Bala Chandran, Clark Bloomer, Robert D. Schreiber, Amy M. Fowler, Alexis K. Smith, Natasha Girgis, Raluca Verona, Iqbal S. Grewal, Michael Quigley and Douglas H. Yamada. Their work appears in journals such as Journal of Nuclear Medicine, Virology, Cell Death and Differentiation, Clinical Cancer Research and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.